The VELOCIMMUNE brand, founded in 2002 (United States), from 16 sister brands and 2214 competing brands. VELOCIMMUNE is owned by Regeneron Pharmaceuticals, listed on the stock exchange of New York The sector of VELOCIMMUNE is Biotechnology.
Investment simulator :
Portfolio valuation
Regeneron Pharmaceuticals
(VELOCIMMUNE)
over 5 years*
USD 2,408.71